GlassScriptPhysician profile
Tiffany Dyson
NPI 1821760083
$3,371.87
in general payments reported to CMS, 2019-2025
13 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $750 · 2022: $766 · 2023: $617 · 2024: $1,054 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,844 · Education: $12.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,844.19 |
| Education | $12.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $797.84 | 2021-2024 | Invega Sustenna, Invega Trinza |
| Teva Pharmaceuticals USA, INC. | $454.58 | 2021-2024 | Austedo Xr, Uzedy, Austedo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $390.32 | 2021-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $386.00 | 2021-2024 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Vanda Pharmaceuticals INC. | $338.63 | 2021-2025 | Fanapt |
| Alkermes, INC. | $262.95 | 2021-2024 | Lybalvi, Aristada |
| Abbvie INC. | $226.08 | 2021-2024 | |
| Lundbeck LLC | $187.66 | 2021-2024 | Rexulti |
| Neurocrine Biosciences, INC. | $107.18 | 2021-2024 | Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $67.29 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $66.26 | 2025 | Cobenfy |
| Almatica Pharma LLC | $62.67 | 2021-2024 | Loreev Xr |
| Tempus Ai, INC | $24.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Dyson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.